Add-on Acquisition • Life Science

Cofactor Genomics Acquires Narus Biotechnologies

On February 5, 2016, Cofactor Genomics acquired life science company Narus Biotechnologies

Acquisition Context

This is Cofactor Genomics’ 1st transaction in the Life Science sector.
This is Cofactor Genomics’ 1st transaction in the United States.
This is Cofactor Genomics’ 1st transaction in California.

Explore All 3109 Add-on Acquisition Life Science Deals - Search the Database Free

M&A Deal Summary
Date	February 5, 2016
Target	Narus Biotechnologies
Sector	Life Science
Buyer(s)	Cofactor Genomics
Deal Type	Add-on Acquisition

Target Company

Narus Biotechnologies

San Francisco, California, United States

Narus Biotechnologies, Inc. is an early-stage molecular diagnostics company focused on helping physicians treat neurological diseases.

Explore More Deals

Browse All 215,156 Deals

FILTER BY

Buyer Type (PE or Strategic)
Deal Size ($10M to $10B+)
Sector (60 Sectors)
Deal Type
Geography
& More

Search Free

Buyer Overview 1

Buyer

Cofactor Genomics

St. Louis, Missouri, United States

Category	Company
Sector	Life Science

DESCRIPTION

Cofactor Genomics is a biotechnology company that develops a platform based on RNA that enables early detection and diagnosis of a disease. Cofactor Genomics is based in St. Louis, Missouri.

Deal Context for Buyer	#
Overall	1 of 1
Sector: Life Science	1 of 1
Type: Add-on Acquisition	1 of 1
State: California	1 of 1
Country: United States	1 of 1
Year: 2016	1 of 1

Explore Related M&A Activity

Life Science M&A - Add-on Acquisition M&A Deals - California M&A - United States M&A - 2016 M&A